WHO ICTRP trial
Oral labetalol versus oral alpha methyl dopa for managing preeclampsia at the…
PACTR202510836146767 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR202510836146767 |
|---|---|
| Public title | Oral labetalol versus oral alpha methyl dopa for managing preeclampsia at the University of Maiduguri Teaching Hospital: A randomized controlled study. |
| Scientific title | Oral labetalol versus oral alpha methyl dopa for managing preeclampsia at the University of Maiduguri Teaching Hospital: A randomized controlled study. |
| Primary sponsor | Dr Fatima Rais Umar |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Nigeria |
| Conditions | Preeclampsia ;Preeclampsia |
| Interventions | Labetalol ;Alpha methyl dopa |
| Registration date | Oct 22, 2025 |
| Target size | 108 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: